Glioblastoma Clinical Trials in Phoenix, AZ

Glioblastoma Clinical Trials in Phoenix, AZ

View the best 10 glioblastoma medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Glioblastoma clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for glioblastoma in Phoenix, Arizona

Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Mayo Clinic in Rochester in Rochester, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is testing pembrolizumab in combination with standard therapy (temozolomide and radiation therapy) to see if it can help treat patients with glioblastoma by killing tumor cells.
Image of Phoenix Childrens Hospital in Phoenix, United States.

Dabrafenib +1 More

Kinase Inhibitor

Recruiting3 awardsPhase 4
This trial is studying the effects of two cancer medications, dabrafenib and trametinib, in children. These drugs work by stopping signals that make cancer cells grow. Dabrafenib and trametinib have shown benefits in various BRAF-mutant tumors, including melanoma, lung cancer, and thyroid cancer. The goal is to see how these treatments affect children over time.
Image of Barrow Neurological Institute (SJHMC) in Phoenix, United States.

Intraoperative radiotherapy

Recruiting2 awardsPhase 3
This trial is testing if adding intraoperative radiotherapy (IORT) to standard radiochemotherapy can improve the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM).
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial tests if adding GammaTile radiation therapy to standard treatment can improve outcomes for patients with newly diagnosed GBM. GammaTile delivers quick, direct radiation to the tumor, which may help control the tumor better and improve survival rates.
Image of Mayo Clinic in Rochester, United States.

Retifanlimab

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests if retifanlimab + bevacizumab + radiation can improve treatment of recurrent glioblastoma. Protein and drugs may help immune system fight cancer & stop blood vessels supplying tumor.
Image of Mayo Clinic in Phoenix, United States.

Retifanlimab +3 More

Immune Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing a combination of treatments including a new drug, radiation therapy, and other medications for patients with aggressive brain cancer that has returned. The goal is to boost the body's immune system to better fight the cancer, shrink tumors, and help patients live longer.
Image of Children's Oncology Group in Philadelphia, United States.

Selinexor +1 More

Selective Inhibitors of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.